![Barbara Domayne Hayman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barbara Domayne Hayman
Lid van de Investeringscommissie bij Cambridge Enterprise Ltd.
Actieve functies van Barbara Domayne Hayman
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Cambridge Enterprise Ltd.
![]() Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Lid van de Investeringscommissie | - | - |
Autifony Therapeutics Ltd.
![]() Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Loopbaan van Barbara Domayne Hayman
Opleiding van Barbara Domayne Hayman
University of Oxford | Doctorate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 4 |
Operationeel
Investment Committee Member | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sectoraal
Finance | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Cambridge Enterprise Ltd.
![]() Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Finance |
Autifony Therapeutics Ltd.
![]() Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Autifony Therapeutics Ltd. discovers and develops new pharmaceutical treatments treat hearing disorders. The firm focuses on the treatment of hearing disorders, including noise-induced hearing loss and tinnitus. The company was founded by Charles H. Large and Giuseppe S. Alvaro in 2011 and is headquartered in London, the United Kingdom. | Health Technology |